Abstract
Objective
Malignant osseous spinal neoplasms are aggressive tumors associated with poor outcomes despite aggressive multidisciplinary measures. While surgical resection has been shown to improve short-term local disease control, it remains debated whether surgical resection is associated with improved overall survival in patients with malignant primary osseous spinal neoplasms. The aim of this manuscript is to review survival data from a US cancer registry spanning 30 years to determine if surgical resection was independently associated with overall survival.
Methods
The SEER registry (1973–2003) was queried to identify cases of histologically confirmed primary spinal chordoma, chondrosarcoma, osteosarcoma, or Ewing’s sarcoma of the mobile spine and pelvis. Patients with systemic metastasis were excluded. Age, gender, race, tumor location, and primary treatments were identified. Extent of local tumor invasion was classified as confined within periosteum versus extension beyond periosteum to surrounding tissues. The association of surgical resection with overall survival was assessed via Cox analysis adjusting for age, radiotherapy, and tumor invasiveness.
Results
827 patients were identified with non-metastatic primary osseous spinal neoplasms (215 chordoma, 282 chondrosarcoma, 158 osteosarcoma, 172 Ewing’s sarcoma). Overall, median survival was histology specific (chordoma, 96 months; Ewing’s sarcoma, 90 months; chondrosarcoma, 88 months; osteosarcoma, 18 months). Adjusting for age, radiation therapy, and extent of local tumor invasion in patients with isolated (non-metastatic) spine tumors, surgical resection was independently associated with significantly improved survival for chordoma [hazard ratio (95 % confidence interval; 0.617 (0.25–0.98)], chondrosarcoma [HR (95 %CI); 0.153 (0.07–0.36)], osteosarcoma [HR (95 %CI); 0.382 (0.21–0.69)], and Ewing’s sarcoma [HR (95 %CI); 0.494 (0.26–0.96)].
Conclusion
In our analysis of a 30-year US population-based cancer registry (SEER), patients undergoing surgical resection of primary spinal chordoma, chondrosarcoma, Ewing’s sarcoma, or osteosarcoma demonstrated prolonged overall survival independent of patient age, extent of local invasion, or location. Surgical resection may play a role in prolonging survival in the multi-modality treatment of patients with these malignant primary osseous spinal neoplasms.
Similar content being viewed by others
References
American Cancer Society (2008) Cancer Facts & Figures 2008. American Cancer Society, Atlanta
Arai Y, Kun LE, Brooks MT, Fairclough DL, Fontanesi J, Meyer WH et al (1991) Ewing’s sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys 21:1501–1508
Bacci G, Boriani S, Balladelli A, Barbieri E, Longhi A, Alberghini M et al (2009) Treatment of nonmetastatic Ewing’s sarcoma family tumors of the spine and sacrum: the experience from a single institution. Eur Spine J 18:1091–1095
Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG (2001) Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 91:1201–1212
Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88:2122–2134
Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M et al (2006) Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976) 31:493–503
Boriani S, De Iure F, Bandiera S, Campanacci L, Biagini R, Di Fiore M et al (2000) Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976) 25:804–812
Bovill EG Jr, Kung’u A, Bencivenga A, Jeshrani MK, Mbindyo BS, Heda PM (1985) An epidemiological study of osteogenic sarcoma in Kenya: the variations in incidence between ethnic groups and geographic regions, 1968–1978. Int Orthop 9:59–63
Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr (1999) Lumbosacral chordoma. Prognostic factors and treatment. Spine (Phila Pa 1976) 24:1639–1645
DeLaney TF, Park L, Goldberg SI, Hug EB, Liebsch NJ, Munzenrider JE et al (2005) Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 61:492–498
Dorfman HD, Czerniak B (1995) Bone cancers. Cancer 75:203–210
Evans RG, Nesbit ME, Gehan EA, Garnsey LA, Burgert O Jr, Vietti TJ et al (1991) Multimodal therapy for the management of localized Ewing’s sarcoma of pelvic and sacral bones: a report from the second intergroup study. J Clin Oncol 9:1173–1180
Fourney DR, Rhines LD, Hentschel SJ, Skibber JM, Wolinsky JP, Weber KL et al (2005) En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine 3:111–122
Gherlinzoni F, Picci P, Bacci G, Campanacci D (1992) Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. Ann Oncol 3(Suppl 2):S23–S27
Grubb MR, Currier BL, Pritchard DJ, Ebersold MJ (1994) Primary Ewing’s sarcoma of the spine. Spine (Phila Pa 1976) 19:309–313
Hsieh PC, Xu R, Sciubba DM, McGirt MJ, Nelson C, Witham TF et al (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 34:2233–2239
Ito E, Saito K, Okada T, Nagatani T, Nagasaka T (2010) Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence. Acta Neurochir (Wien) 152:57–67 discussion 67
Larsson SE, Lorentzon R (1974) The incidence of malignant primary bone tumours in relation to age, sex and site. A study of osteogenic sarcoma, chondrosarcoma and Ewing’s sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Jt Surg Br 56B:534–540
Link MP, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A et al (1991) Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res 8–14
Marco RA, Gentry JB, Rhines LD, Lewis VO, Wolinski JP, Jaffe N et al (2005) Ewing’s sarcoma of the mobile spine. Spine (Phila Pa 1976) 30:769–773
Marmor E, Rhines LD, Weinberg JS, Gokaslan ZL (2001) Total en bloc lumbar spondylectomy. Case report. J Neurosurg 95:264–269
McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12:1–11
Navid F, Willert JR, McCarville MB, Furman W, Watkins A, Roberts W et al (2008) Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer 113:419–425
Oyemade GA, Abioye AA (1982) Primary malignant tumors of bone: incidence in Ibadan, Nigeria. J Natl Med Assoc 74:65–68
Ozaki T, Flege S, Liljenqvist U, Hillmann A, Delling G, Salzer-Kuntschik M et al (2002) Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group. Cancer 94:1069–1077
Paulino AC, Nguyen TX, Mai WY (2007) An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma. Pediatr Blood Cancer 48:423–429
Price CH, Jeffree GM (1977) Incidence of bone sarcoma in SW England, 1946–74, in relation to age, sex, tumour site and histology. Br J Cancer 36:511–522
Rao G, Suki D, Chakrabarti I, Feiz-Erfan I, Mody MG, McCutcheon IE et al (2008) Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine 9:120–128
Sciubba DM, Okuno SH, Dekutoski MB, Gokaslan ZL (2009) Ewing and osteogenic sarcoma: evidence for multidisciplinary management. Spine (Phila Pa 1976) 34:S58–S68
Shives TC, Dahlin DC, Sim FH, Pritchard DJ, Earle JD (1986) Osteosarcoma of the spine. J Bone Jt Surg Am 68:660–668
Shives TC, McLeod RA, Unni KK, Schray MF (1989) Chondrosarcoma of the spine. J Bone Jt Surg Am 71:1158–1165
Stacchiotti S, Marrari A, Tamborini E, Palassini E, Virdis E, Messina A et al (2009) Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 20:1886–1894
Sundaresan N, Rosen G, Boriani S (2009) Primary malignant tumors of the spine. Orthop Clin North Am 40:21–36, v
Sundaresan N, Rosen G, Huvos AG, Krol G (1988) Combined treatment of osteosarcoma of the spine. Neurosurgery 23:714–719
Wagner LM, McAllister N, Goldsby RE, Rausen AR, McNall-Knapp RY, McCarville MB et al (2007) Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatr Blood Cancer 48:132–139
Weber KL (2002) Current concepts in the treatment of Ewing’s sarcoma. Expert Rev Anticancer Ther 2:687–694
York JE, Berk RH, Fuller GN, Rao JS, Abi-Said D, Wildrick DM et al (1999) Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg 90:73–78
York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA et al (1999) Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44:74–79 (discussion 79–80)
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mukherjee, D., Chaichana, K.L., Parker, S.L. et al. Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database. Eur Spine J 22, 1375–1382 (2013). https://doi.org/10.1007/s00586-012-2621-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-012-2621-4